Skip to main content

Improve Efficiency and Increase Confidence in Biopharmaceutical Discovery and Development

Discovering and Developing biopharmaceuticals can be costly and difficult. At every stage of disease research and drug development Agilent can provide you with the analytical answers you need to make the right choices and bring your biotherapeutics to the market successfully.

We understand that big decisions are often made from small data, so you need to be confident the first time. You can count on Agilent to continually advance the state of the art for unambiguously identifying and validating protein biomarkers and in the discovery, identification, characterization, and quantitation of proteins or antibodies. We have the instruments so you can capture the essential information you need to be sure.

From sample preparation to data analysis, we demonstrate how to obtain the answer fast using Agilent’s analytical instruments, automation products, bio-inert systems, columns, and reagents, along with extensive data-processing and reporting software to support regulatory compliance and QbD.

Rest assured with Agilent reliability

Product robustness and reliability, together with trusted service, provide peace of mind when you choose Agilent. We can help you streamline your analysis and speed your new biologic candidates through the approval process.

Follow Agilent’s Pharma LinkedIn Showcase:
Follow us on LinkedIn for continuous up to date Pharma news, events, publications and more

For Research Use Only. Not for use in diagnostic procedures.
Featured Application Notes

Precise Characterization of Intact mAbs by the Agilent 6545XT AdvanceBio LC/Q-TOF